IMO, there are few issues we should know ( but we do not know) and those could explain why nobody is telling anything. To be worth of anything this invention needs to get a patent. PBT2 has a patent but not in treating these bad infections, new application is needed. I think that Bohlmann et al have made the needed patent application for their invention but they did not want to tell this to Prana. However I would think that Prana is now talking with Bohlmann et al to get some ownership in this new patent or they may have other plans how they could extend their present PBT2 patent to cover also these bad infections. These negotiations are never easy and the worst what you can do is to present your patent arguments or plans openly before there is an application made and even approved. These things are secret. But thanks to Headset Prana and it's inventor Barnham now know how valuable PBT2 can be in treating infections. Unfortunately the news came just when the Sinclair negotiations were finished. But as I told, we do not know if this is the case explaining why it is difficult to get any answers.
PBT Price at posting:
4.4¢ Sentiment: None Disclosure: Held
